ICS 2018 Workshop 9 - Radiotherapy of cervical and endometrial cancer – Prevention and management of lower urinary tract, vaginal, vulvar and pelvic floor dysfunction in cancer survivors

Speakers
	Workshop 9
	Tuesday 28th August 2018
	11:00 - 12:30
	Hall H Capacity: 110
	Lunch provided
A Amy D. Dobberfuhl, MD, MS Workshop Chair E Elizabeth Kidd Workshop Speaker B Bertha H Chen Workshop Speaker S Stephanie Bernard Workshop Speaker
Links
Workshop Handout Download PDF Workshop Evaluation Give feedback on your workshop Workshop Slides Download presentation PDF's Workshop Admin

11:00

Minimising radio-toxicity to benign tissues (Radiation Oncologist)

Elizabeth Kidd

11:20

Acute and chronic lower urinary tract dysfunction (Urologist)

Amy D. Dobberfuhl, MD, MS

11:40

Discussion

Amy D. Dobberfuhl, MD, MS

Elizabeth Kidd

11:45

Physiotherapy of the radiated pelvic floor (Pelvic Floor Physiotherapist)

Stephanie Bernard

12:05

Radiation induced vaginal dysfunction (Urogynaecologist)

Bertha H Chen

12:25

Discussion

Stephanie Bernard

Bertha H Chen

Level	Basic
Duration	90 minutes
Category	Female Lower Urinary Tract Symptoms (LUTS) / Voiding Dysfunction
Research Type	Clinical
Keywords	Cervical and endometrial cancer Radiotherapy Complications
Target Audience	Providers (MD, NP, PA, RN) who evaluate and care for women with lower urinary tract symptoms, hematuria, prolapse or pelvic floor dysfunction following pelvic radiotherapy.
Aims and Objectives	This course will outline the epidemiology of cervical and endometrial cancer throughout the world. Treatment options will be discussed with an emphasis on pelvic radiotherapy and the latest trends to minimise treatment related side effects. Representative patient case presentations will be used to highlight the urologic, gynaecologic and physiotherapy management options for acute and late complications of radiotherapy on the bladder, lower urinary tract, vagina and pelvic floor. Learning Objectives 1) What are the potential urinary side effects from pelvic radiation and brachytherapy and how can this toxicity be decreased or minimised for cervical and endometrial cancer patients requiring radiation therapy as part of their treatment? 2) What are the latest trends for managing the acute and late complications of radiotherapy on the bladder, lower urinary tract and pelvic floor? 3) Where should future research efforts be directed to minimise and treat the long term unintended side effects of pelvic radiotherapy in women?